Wolowacz S, Mauskopf J, Earnshaw SR. Estimating condition-related costs. In: Mauskopf J, Earnshaw SR, editors. Budget-impact analysis of health care interventions: a practical guide. 1st ed. Cham: Switzerland. Springer International Publishing AG; 2017. p.91-101. doi: 10.1007/978-3-319-50482-7

In this chapter, we discuss how to estimate any changes in condition-related costs and outcomes that might be expected to occur as a result of the introduction of the new drug to the formulary. These changes should be included in the budget-impact estimates if they are likely to occur within the analysis time horizon and if there are credible clinical data that indicate that such changes are likely.Condition-related costs and outcomes that occur beyond the analysis time horizon may also be important to consider within an analysis.Consideration of these costs along with condition-related costs and outcomes that might occur for an incident versus a prevalent population are discussed.

Share on: